| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
PAPER |
1 Department of Neurology, Beaumont Hospital, Dublin, Ireland
2 The Irish MND Association, Coleraine House, Dublin, Ireland
Correspondence to:
Correspondence to:
Dr Traynor, Massachusetts General Hospital East, Cecil B. Day Lab, Building 114, Room 3125, 16th Street, Charlestown, MA 02129, USA;
btraynor{at}partners.org
Background: In recent years, there has been a paradigm shift in the method of healthcare delivery to amyotrophic lateral sclerosis (ALS) patients with the emergence of multidisciplinary ALS clinics that cater exclusively for patients with this condition. The impact of multidisciplinary management has not been previously evaluated.
Methods: Using data from the Irish ALS Register, we conducted a prospective, population based study of all ALS cases diagnosed in Ireland over a five year period to evaluate the effectiveness of a multidisciplinary clinic on ALS survival.
Results: Eighty two (24%) patients attended the multidisciplinary ALS clinic, with the remaining 262 (76%) cases followed in a general neurology clinic. The ALS clinic cohort was an average of five years younger (60.1 v 65.6 years) and were more likely to receive riluzole than the general neurology cohort (99% v 61%). The median survival of the ALS clinic cohort was 7.5 months longer than for patients in the general neurology cohort (logrank = 15.4, p < 0.0001). Overall, one year mortality was decreased by 29.7%. Prognosis of bulbar onset patients was extended by 9.6 months if they attended the ALS clinic. Using multivariate analysis, attendance at the ALS clinic was an independent covariate of survival (HR = 1.47, p = 0.02).
Conclusions: ALS patients who received their care at a multidisciplinary clinic had a better prognosis than patients attending a general neurology clinic. The data suggest that active and aggressive management enhances survival, particularly among ALS patients with bulbar dysfunction. The effect of clinic type must be considered in future clinical trials design.
Keywords: amyotrophic lateral sclerosis; Ireland; multidisciplinary clinic; survival; population based
Abbreviations: ALS, amyotrophic lateral sclerosis; IMNDA, Irish Motor Neurone Disease Association; NIPPV, non-invasive positive pressure ventilation
This article has been cited by other articles:
|
|
 |
|
  C. J McDermott and P. J Shaw Diagnosis and management of motor neurone disease BMJ, March 22, 2008; 336(7645): 658 - 662. [Full Text] [PDF]
|
|
|
|
 |
|
 G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mitsumoto and J. G. Rabkin Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best" JAMA, July 11, 2007; 298(2): 207 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Sorenson, J. Mandrekar, B. Crum, and J. C. Stevens Effect of referral bias on assessing survival in ALS Neurology, February 20, 2007; 68(8): 600 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cronin, M. J. Greenway, S. Ennis, D. Kieran, A. Green, J.H.M. Prehn, and O. Hardiman Elevated serum angiogenin levels in ALS Neurology, November 28, 2006; 67(10): 1833 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dubinsky, J. Chen, and S.-M. Lai Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort. Neurology, September 12, 2006; 67(5): 777 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Chio, E Bottacchi, C Buffa, R Mutani, G Mora, and the PARALS Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(8): 948 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Czaplinski, A. A. Yen, E. P. Simpson, and S. H. Appel Slower Disease Progression and Prolonged Survival in Contemporary Patients With Amyotrophic Lateral Sclerosis: Is the Natural History of Amyotrophic Lateral Sclerosis Changing? Arch Neurol, August 1, 2006; 63(8): 1139 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chi, Y. Ke, C. Luo, B. Li, D. Gozal, B. Kalyanaraman, and R. Liu Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration, and Neurogenesis in the Spinal Cords of Amyotrophic Lateral Sclerosis Mice Stem Cells, January 1, 2006; 24(1): 34 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Van den Berg, S. Kalmijn, E. Lindeman, J. H. Veldink, M. de Visser, M. M. Van der Graaff, J.H.J. Wokke, and L. H. Van den Berg Multidisciplinary ALS care improves quality of life in patients with ALS Neurology, October 25, 2005; 65(8): 1264 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mulvey J. Oncol. Pract, September 1, 2005; 1(3): 82 - 83. [Full Text] [PDF]
|
|
|
|
|
|
R B Forbes, S Colville, G W Cran, and R J Swingler Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1753 - 1755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Hutchinson, R Galvin, B Sweeney, T Lynch, R Murphy, J Redmond, B J Traynor, and O Hardiman Effect of a multidisciplinary clinic on survival in amyotrophic lateral sclerosis * Author's reply J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1208 - 1209. [Full Text] [PDF]
|
|
|
|
|
|
P N Leigh, S Abrahams, A Al-Chalabi, M-A Ampong, L H Goldstein, J Johnson, R Lyall, J Moxham, N Mustfa, A Rio, et al. The management of motor neurone disease J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(90004): iv32 - 47. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
